Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · USD
$109
-1.24 (-1.1%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first MNPR analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 730.8M | |
|---|---|---|
| Net income (ttm) | -15M | |
| EPS (ttm) | -$1.92 | |
| Shares out | 6.7M | |
| Volume | 528,908 | |
| Beta | 1.47 | |
| Price target | $114 | +4.2% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Net income (ttm)
- -15M
- EPS (ttm)
- -$1.92
- Market cap
- 730.8M
Fair-value bridge
- Current price
- $109
Analyst consensus
Recommendation
Strong Buy
Price target
$114
+4.2%
In the news
Latest news · MNPR
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 730.8M
- P/B
- 5.4x
Profitability
- ROE
- -15.9%
- ROA
- -12.1%
- ROIC
- -12.4%
Balance sheet
- Debt / equity
- 0.00
- Current ratio
- 56.04
- Quick ratio
- 55.94
Trading
- Beta
- 1.47
- Volume
- 528,908
- Dividend yield
- 0.0%